Covalon Receives FDA Clearance for Antimicrobial Silicone Wound Dressing
Covalon Technologies has announced it has received FDA clearance for a new antimicrobial silicone adhesive film dressing, according to a news release.
The SurgiClear antimicrobial silicone adhesive film dressing is designed to cover and protect wound sites and wound closure devices, as well as secure other primary dressings to a patient's skin, according to the company.
"The FDA clearance of SurgiClear, the clearance of its sister product IV Clear a few months ago and very strong clinical feedback received to date provides Covalon with all of the validity necessary to license and sell both products," said Brian Pedlar, Covalon's CEO, in the release. "Every year in the United States, over 48 million in-patient procedures result in wounds that could benefit from SurgiClear's antimicrobial silicone technology."
Covalon Technologies is headquartered in Ontario, Canada.
Related Articles on FDA Clearances:
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.